Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury

Clinical trial NCT06677229 · RECRUITING

Trial details

NCT number: NCT06677229
Sponsor: Technophage, SA
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Spinal Cord Injury (SCI)

Start date: 2025-08-01
Primary completion: 2026-12-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.